Contractor
Roche Farma S.A.
ESP / Madrid / 28042
Total awarded
€64.07M
Award notices won
26
Lots won
60
Last award
Jun 24, 2026
Awarded lots
| Lot | CPV | Contract nature | Award value | Estimated value | Place | Award criteria |
|---|---|---|---|---|---|---|
LOT-0015 / OCRELIZUMAB 300 MG CONCENTRADO PARA SOLUCION PARA PERFUSIÓN | 33652000 | supplies | €7.43M | €22.90M | - | price |
LOT-0002 / LOTE DOS–ASOCIACIÓN DE PERTUZUMAB (DOE) Y TRASTUZUMAB (DOE) | 33600000 | supplies | €4.86M | - | ESP | price |
LOT-0001 / ATEZOLIZUMAB 1.200 MG/20 ML 1 VIAL / ATEZOLIZUMAB 1.875 MG/15 ML 1 VIAL | 33652100 | supplies | €4.72M | €10.38M | ESP / Santiago de Compostela | price / 100 |
LOT-0001 / Suministro de Entrectinib (DOE) | 33600000 | supplies | €4.67M | - | - | price |
LOT-0016 / PERTUZUMAB 420 MG VIAL CONCENTRADO PARA SOLUCION PARA PERFUSION | 33652000 | supplies | €4.40M | €1.35M | - | price |
LOT-0000 / Suministro del medicamento Phesgo 600 mg/600 mg Solución para inyección 1 vial de 10 ml Principio activo Pertuzumab/Trastuzumab, de cuantía indeterminada (Disp. Adicional 33 de la Ley 9 /2017 de Contratos del S. Público)mediante procedimiento negociado sin publicidad y tramitación ordinaria con destino el Serv. de Farmacia del Hospital Universitario Ntra Sra de Candelaria | 33693000 | supplies | €3.90M | - | - | price / 100 |
LOT-0026 / ATEZOLIZUMAB 1200 MG VIAL CONCENTRADO PARA SOLUCION PARA PERFUSIÓN | 33652000 | supplies | €2.99M | €1.63M | - | price |
LOT-0001 / 1 - TRASTUZUMAB EMTANSINA (DOE) | 33600000 | supplies | €2.94M | - | - | price |
LOT-0018 / Emicizumab 150 mg/1ml (150mg/ml) vial sc | 33690000 | supplies | €2.69M | €5.92M | ESP | price / 100 |
LOT-0011 / TRASTUZUMAB 600 MG VIAL SOLUCION INYECTABLE SUBCUTANEA | 33620000 | supplies | €2.55M | €8.50M | - | price |
LOT-0012 / TRASTUZUMAB EMTANSINA 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | 33652000 | supplies | €1.64M | €7.33M | - | price |
LOT-0015 / Emicizumab 60 mg/0,4ml (150mg/ml) vial sc | 33690000 | supplies | €1.59M | €3.50M | ESP | price / 100 |
LOT-0013 / TRASTUZUMAB EMTANSINA 160 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | 33652000 | supplies | €1.41M | €3.51M | - | price |
LOT-0003 / SATRALIZUMAB 120 MG 1 JERINGA PRECARGADA 1ML SOLUCION INYECTABLE | 33652000 | supplies | €1.28M | €1.07M | - | price |
LOT-0000 / Suministro de FARICIMAB 120 MG/ML 0,24 ML Vial (VABYSMO) de distribución exclusiva con destino al Servicio de Farmacia del Hospital Clínico San Carlos de Madrid. | 33600000 | supplies | €1.07M | €1.83M | ESP / Madrid | cost |
LOT-0001 / ALECTINIB 150 MG CAPSULAS | 33652000 | supplies | €980,241 | €1.73M | - | price |
LOT-0008 / EMICIZUMAB 150 MG VIAL 1 ML | 33620000 | supplies | €915,270 | €475,940 | - | price |
LOT-0002 / 2 - OBINUTUZUMAB (DOE) | 33600000 | supplies | €872,928 | - | - | price |
LOT-0018 / PERTUZUMAB 600MG/TRASTUZUMAB 600 MG SOLUCION PARA INYECCION VIAL 10 ML | 33652000 | supplies | €833,464 | €1.19M | - | price |
LOT-0001 / Pertuzumab/Trastuzumab 600 mg/600 mg inyectable 10 ml | 33600000 | supplies | €825,125 | €1.40M | ESP / Leganés (Madrid) | price |
LOT-0019 / Atezolizumab 840 mg/14 ml vial perf iv | 33690000 | supplies | €758,719 | €1.67M | ESP | price / 100 |
LOT-0010 / EMICIZUMAB 60MG/0,4 ML (150 MG/ML) VIAL | 33620000 | supplies | €732,220 | €14.34M | - | price |
LOT-0014 / RITUXIMAB 1400MG VIAL 1400 MG/11,7 ML SOLUCION PARA INYECCION SUBCUTANEA | 33652000 | supplies | €624,371 | €38.64M | - | price |
LOT-0001 / MEDICAMENTOS EXCLUSIVOS | 33690000 | supplies | €619,230 | - | - | price |
LOT-0000 / Suministro del producto farmacéutico (Risdiplam), para el Complejo Hospitalario Universitario Insular-Materno Infantil de Gran Canaria. | 33690000 | supplies | €614,579 | - | - | price / 100 |
LOT-0005 / RISDIPLAM 0,75MG/ML SOLUCION ORAL | 33661700 | supplies | €606,492 | €2.27M | - | price |
LOT-0000 / El objeto del contrato viene determinado por el suministro del fármaco denominado "PHESGO 600 MG/600 MG SC C/1". | 33690000 | supplies | €562,586 | - | - | price / 100 |
LOT-0000 / Suministro del medicamento Polivy (Principio activo Polatuzumab 30 mg vial perf IV) de cuantia indeterminada (Disposición adicional 33 de la Ley 9/2017 de Contratos del Sector Público, mediante procedimiento negociado sin publicidad y tramitación ordinaria, con destino el servicio de Farmacia del Hospital Universitario Nuestra Señora de Candelaria, a realizar por la empresa Roche Farma S.A. | 33690000 | supplies | €472,483 | - | - | price / 100 |
LOT-0001 / 1 - HEMLIBRA | 33600000 | supplies | €457,635 | €457,650 | ESP / Logroño | cost / 100 |
LOT-0047 / Lote 47 - Fármacos exclusivos de ROCHE FARMA S.A | 33600000 | supplies | €454,854 | €1.23M | ESP / Barcelona | price |
LOT-0001 / MEDICAMENTOS EXCLUSIVOS | 33690000 | supplies | €447,450 | - | - | price |
LOT-0006 / OBINUTUZUMAB 1000 MG VIAL CONCENTRADO PARA SOLUCION PARA PERFUSIÓN 40 ML | 33652000 | supplies | €436,464 | €1.67M | - | price |
LOT-0017 / Emicizumab 105 mg/0,7ml (150mg/ml) vial sc | 33690000 | supplies | €435,669 | €958,472 | ESP | price / 100 |
LOT-0001 / Ocrevus vial 300 mg | 33652200 | supplies | €412,820 | - | - | price |
LOT-0000 / Suministro de medicamento exclusivo Emicizumab | 33000000 | supplies | €390,273 | - | - | quality / 10 |
LOT-0002 / COBIMETINIB 20 MG COMPRIMIDOS | 33652000 | supplies | €331,782 | €6.63M | - | price |
LOT-0001 / Risdiplam 60mg/80ml oral | 33690000 | supplies | €327,506 | €327,506 | ESP | price / 100 |
LOT-0007 / EMICIZUMAB 105MG/0,7ML (150MG/ML) VIAL | 33620000 | supplies | €320,345 | €4.76M | - | price |
LOT-0001 / Ocrelizumab | 33652300 | supplies | €309,615 | €681,153 | ESP / Madrid | price / 50 |
LOT-0003 / 3 - OCREVUS | 33600000 | supplies | €309,615 | €309,615 | ESP / Logroño | cost / 100 |
LOT-0000 / Suministro farmacéutico del principio activo Pertuzumab/Trastuzumab. | 33690000 | supplies | €305,423 | - | - | price / 100 |
LOT-0017 / PERTUZUMAB 1200MG/TRASTUZUMAB 600 MG SOLUCION PARA INYECCION VIAL 15 ML | 33652000 | supplies | €259,000 | €22.90M | - | price |
LOT-0001 / LOTE UNO– FARICIMAB (DOE) | 33600000 | supplies | €223,725 | - | ESP | price |
LOT-0004 / VISMODEGIB 150 MG CAPSULAS | 33652000 | supplies | €206,546 | €3.27M | - | price |
LOT-0002 / Faricimab 120 mg/ml solución inyectable | 33690000 | supplies | €186,139 | €186,139 | ESP | price / 100 |
LOT-0002 / 2 - KADCYLA | 33600000 | supplies | €169,830 | €169,830 | ESP / Logroño | cost / 100 |
LOT-0002 / Pertuzumab/Trastuzumab 1200 mg/600 mg inyectable 15 ml | 33600000 | supplies | €116,550 | €198,135 | ESP / Leganés (Madrid) | price |
LOT-0000 / Acuerdo Marco de Suministro de medicamento exclusivo EMICIZUMAB para los Órganos Periféricos del Servicio Cántabro de Salud (AM SCS 2022/76) | 33000000 | supplies | €97,568 | - | - | quality / 10 |
LOT-0009 / EMICIZUMAB 30 MG/ML VIAL 1 ML | 33620000 | supplies | €91,527 | €3.81M | - | price |
LOT-0002 / Pertuzumab 1200 mg/Trastuzumab 600 mg SC | 33690000 | supplies | €87,413 | €87,413 | ESP | price / 100 |
LOT-0016 / Emicizumab 30 mg/1 ml (30mg/ml) vial sc | 33690000 | supplies | €80,544 | €177,196 | ESP | price / 100 |
LOT-0021 / DORNASA ALFA 2500 UI/2,5 ML SOLUCION INHALACION NEBULIZADOR | 33652000 | supplies | €52,499 | €3.06M | - | price |
LOT-0001 / ALECENSA 150 MG, 224 capsulas | 33000000 | supplies | - | - | - | price |
LOT-0002 / PHESGO 600 mg/600 mg , 1 vial de 10 ml | 33000000 | supplies | - | - | - | price |
LOT-0000 / Lote 1 SUM | 33600000 | supplies | - | - | ESP | price |
LOT-0001 / HERCEPTIN 600 MG, 1 VIAL | 33000000 | supplies | - | - | - | price |
LOT-0002 / MABTHERA 1400 MG, 1 VIAL | 33000000 | supplies | - | - | - | price |
LOT-0004 / HEMLIBRA 105 MG/0,7 ML, 1 VIAL 0,7 ML | 33000000 | supplies | - | - | - | price |
LOT-0005 / EVRYSDI 0,75 MG/ML POLVO SOL ORAL 1 FR 80 ML | 33000000 | supplies | - | - | - | price |
LOT-0027 / VEMURAFENIB 240 MG COMPRIMIDOS RECUBIERTOS | 33652000 | supplies | - | - | - | price |
Award tenders
Company details
Identifiers
A08023145
Countries
ESP
Cities
Madrid
Post codes
28042
Emails
madrid.contratacionpublica@roche.com
CPV codes
Owner nationalities
ESP
About this contractor
Roche Farma S.A. is a contractor that has been awarded public procurement contracts published through official European procurement systems.
This profile summarizes publicly available procurement information, including awarded contract value, awarded lots, procurement history, countries of activity, CPV classifications, and recent contract awards.
FAQ
What information does this contractor profile contain?
This profile summarizes publicly available procurement information about the contractor, including awarded contract values, awarded lots, procurement history, CPV classifications, locations, and company details when available.
What does Total Awarded mean?
Total Awarded represents the total known value of awarded contracts associated with this contractor based on available procurement data.
Why can the awarded value differ from the total contract value?
A contractor may be awarded one or more lots within a procurement procedure. As a result, the contractor's awarded value may differ from the total value of the procurement notice.
What are Awarded Lots?
Awarded lots are individual parts of a procurement procedure that have been awarded to this contractor.
How often is this profile updated?
Contractor profiles are updated automatically when new procurement notices and contract award notices become available.
Why are some company details missing?
Contractor profiles are generated from publicly available procurement notices. Some information, such as contact details or company registration data, may not be available in every notice.
Understanding this contractor profile
This contractor profile is generated from publicly available procurement information published by contracting authorities.
The profile helps procurement professionals, suppliers, researchers, and journalists understand a contractor's participation in public procurement.
Information may include awarded contract values, awarded lots, procurement history, procurement categories (CPV), locations, and contracting authorities.